Trials / Completed
CompletedNCT03263598
Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites
Clinical Significance and Correlation Between the 24-Hour Urine Sodium Excretion and the Spot Urine Na/K Ratio in Cirrhotic Patients With Ascites.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 195 (actual)
- Sponsor
- Jang Byoung Kuk · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The low sodium intake is important for ascites control in liver cirrhosis patients. Therefore, World Health Organization (WHO) recommends reduction of sodium (Na) to 2g/day for adults. The 24-hour urine Na excretion has been regarded as a standard method to estimate the amount of daily dietary sodium intake. However, it is too inconvenient to apply to patients or the general population in practice. For this reason, it has been suggested that a spot urine Na/potassium (K) ratio could be replaced with the 24-hour urine Na excretion. However, the evidence is not sufficient for that. The investigators will evaluate the usefulness of spot urine Na/K ratio to estimate the dietary sodium intake. The investigators will also verify several formulas of estimating the 24-hour Na excretion with spot urine Na, K, Creatinine (Cr).
Detailed description
● Detailed Description: 1. Measurements: they should be performed for 2 days (the urine collected within 24 hrs) * 24-hour urine Na, K and Creatinine (patients were instructed to collect all subsequent urine voids over the next 24-hour period including the first void of the following day.) * Spot urine Na, K, Creatinine with the same urine sample in some containers provided to patients. (every urination) 2. Calculation * Na/K Ratio with spot urine Na, K * Estimating 24-hour urine Na with spot urine Na, K, Cr by using some formulas.
Conditions
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2020-02-01
- Completion
- 2020-02-01
- First posted
- 2017-08-28
- Last updated
- 2020-02-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03263598. Inclusion in this directory is not an endorsement.